Gentamicin in Bacterial Meningitis
Gentamicin is indicated ONLY for neonates less than 1 month old with bacterial meningitis, and should NOT be used in older children or adults. 1, 2
Age-Specific Recommendations
Neonates (<1 Month Old): YES, Use Gentamicin
For neonates, gentamicin is part of standard empiric therapy because the pathogen spectrum differs dramatically from older patients, with Group B Streptococcus and gram-negative enteric bacteria (especially E. coli) predominating 1, 2.
Specific dosing by age:
- Age <1 week: Ampicillin/amoxicillin 50 mg/kg q8h PLUS gentamicin 2.5 mg/kg q12h 1, 2
- Age 1-4 weeks: Ampicillin 50 mg/kg q6h PLUS gentamicin 2.5 mg/kg q8h 1, 2
Alternative regimen: Ampicillin/amoxicillin plus cefotaxime (instead of gentamicin) 1
Rationale: Neonatal meningitis is frequently caused by gram-negative enteric bacilli that require aminoglycoside coverage. The combination of ampicillin (for Listeria and Group B Strep) plus gentamicin (for gram-negatives) provides appropriate empiric coverage 3.
Children (1 Month to 18 Years): NO Gentamicin
Standard treatment: Cefotaxime or ceftriaxone PLUS vancomycin or rifampicin 1, 2
The pathogen spectrum shifts to S. pneumoniae and N. meningitidis, which do not require aminoglycoside coverage.
Adults (>18 Years): NO Gentamicin
Standard treatment:
- Age 18-50 years: Ceftriaxone 2g q12h or cefotaxime 2g q4-6h PLUS vancomycin 1, 2
- Age >50 years OR immunocompromised: Add ampicillin 2g q4h for Listeria coverage 1, 2
Critical Caveat: Intraventricular Gentamicin is CONTRAINDICATED
Never use intraventricular gentamicin for bacterial meningitis. A landmark multicenter controlled trial demonstrated significantly higher mortality (42.9% vs 12.5%) in infants receiving intraventricular gentamicin plus systemic antibiotics compared to systemic therapy alone 4. This finding was so striking that the study was terminated early 5, 4. The Cochrane review confirms this harm (RR 3.43; 95% CI 1.09-10.74) 5.
FDA-Approved Indications
The FDA label for gentamicin does list "serious bacterial infections of the central nervous system (meningitis)" as an approved indication 6. However, this must be interpreted in the context of current evidence-based guidelines that restrict its use to the neonatal population where gram-negative coverage is essential.
Key Clinical Pearls
- Timing is critical: Antibiotics must be started within 1 hour of hospital arrival 1
- Don't delay for imaging: If CT is needed before LP, start empiric antibiotics immediately 1
- Repeat CSF at 48-72 hours in neonates to confirm sterilization 3
- Duration: 14-21 days for neonatal meningitis caused by gram-negative bacilli 3
The evidence is unequivocal: gentamicin's role in bacterial meningitis is limited exclusively to the neonatal period as part of combination therapy targeting the unique pathogen spectrum of this age group.